Showing results (51-60 of 269) with videos related to

Sort By:
Pageof 27
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2011
The absorbed dose to the blood is a better predictor of ablation success than the administered 131I activity in thyroid cancer patientsFrederik A Verburg, Michael Lassmann, Uwe Mäder, et al.
Annals of Nuclear Medicine|November 26, 2013
O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapyReinhart Sweeney, Bülent Polat, Samuel Samnick, et al.
Clinical Endocrinology|December 15, 2018
The time point of completion thyroidectomy has no prognostic impact in patients with differentiated thyroid cancerChristina Lenschow, Uwe Mäder, Christoph-Thomas Germer, et al.
Endocrine-Related Cancer|March 25, 2005
rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive reviewMarkus Luster, Francesco Lippi, Barbara Jarzab, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancerMichael Lassmann, Heribert Hänscheid, Daniela Gassen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2010
Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-upJohannes Biko, Christoph Reiners, Michael C Kreissl, et al.
Clinical Endocrinology|October 30, 2009
A comparison of prognostic classification systems for differentiated thyroid carcinomaFrederik A Verburg, Uwe Mäder, Cas L J J Kruitwagen, et al.
Clinical Chemistry|June 29, 2002
Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulinNils G Morgenthaler, Juergen Froehlich, Johann Rendl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2011
Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin levelHeribert Hänscheid, Frederik Anton Verburg, Johannes Biko, et al.
Pageof 27